A Study With CIT-013 in RA Patients

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Rheumatoid Arthritis

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • BE-02, Antwerp, Belgium

  • Site BE-01, Leuven, Belgium

    Contact: Study coordinator (PI BE-01)
  • DE-04, Bamberg, Germany

    Contact: Study coordinator (PI DE-04)
  • DE-05, Berlin, Germany

    Contact: Study coordinator (PI DE-05)
  • DE-01, München, Germany

    Contact: Study coordinator (PI DE-01)
  • DE-02, München, Germany

    Contact: Study coordinator (PI DE-02)
  • DE-03, Ratingen, Germany

  • NL-02, Amsterdam, Netherlands

  • NL-05, Leeuwarden, Netherlands

    Contact: Study coordinator (PI NL-05)
  • NL-04, Leiden, Netherlands

  • NL-03, Nijmegen, Netherlands

    Contact: Study coordinator (PI NL-03)
  • NL-01, Rotterdam, Netherlands

    Contact: Study coordinator (PI NL-01)
  • PL-01, Bialystok, Poland

    Contact: Study coordinator (PI PL-01)
  • PL-07, Krakow, Poland

    Contact: Study coordinator (PI PL-07)
  • PL-03, Lublin, Poland

    Contact: Study coordinator (PI PL-03)
  • PL-02, Poznan, Poland

    Contact: Study coordinator (PI PL-02)
  • PL-05, Torun, Poland

    Contact: Study coordinator (PI PL-05)
  • PL-04, Warsaw, Poland

    Contact: Study coordinator (PI PL-04)
  • ES-02, A Coruña, Spain

    Contact: Study coordinator (PI ES-02)
  • ES-04, Barcelona, Spain

    Contact: Study coordinator (PI ES-04)
  • ES-05, Barcelona, Spain

    Contact: Study coordinator (PI ES-05)
  • ES-06, Madrid, Spain

    Contact: Study coordinator (PI ES-06)
  • ES-01, Santander, Spain

    Contact: Study coordinator (PI ES-01)
  • ES-03, Santiago de Compostela, Spain

    Contact: Study coordinator (PI ES-03)
מובילי המחקר
  • Maarten Kraan

    Study Director

    Citryll BV